Abstract
3α-androstanediol glucuronide (3αdiolG) is a marker of peripheral tissue androgen metabolism. There are no previous data regarding complete paediatric reference ranges for 3αdiolG. In order to obtain reference values for 3αdiolG we have measured serum levels of 3αdiolG in 283 healthy children and adolescents, 146 boys and 137 girls, age 1 month to 20 years and 28 adults. A non-extraction, solid phase radioimmunoassay employing a polyclonal antiserum that is specific for 3αdiolG was used to measure serum 3αdiolG levels (intra assay variation 5.1–10.1%, inter assay variation 2.7–9.0%). There was a strong sex and age dependence (r=0.8; p<0.0001) of 3αdiolG levels throughout childhood and adolescence with males showing significantly higher levels of the androgen than females (p<0.05). 3αdiolG serum levels (nmol/l±SD) correlated significantly with pubertal stage (p<0.01). Interestingly, in 35 children with CAH serum 3αdiolG levels correlated well with clinical and metabolic status, i.e. 170HP serum levels. In summary, we have established percentile curves for 3αdiolG levels in healthy children and adolescents. We hypothesize that on the basis of our reference values the single measurement of serum 3αdiolG could serve as a means to determine androgen status in children with disorders of puberty and sexual development.
Similar content being viewed by others
References
Morimoto I., Edmiston A., Hawks D., Horton R. Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men. J. Clin. Endocrinol. Metab. 52: 112, 1981.
Moghissi E., Ablan F., Horton R. Origin of plasma androstanediol glucuronide in men. J. Clin. Endocrinol. Metab. 59: 417, 1984.
Vermeulen A., Giagulli V.A. Physiology of plasma androstanediol glucuronide. J. Ster. Biochem. Mol. Biol. 39: 829, 1991.
Rittmaster R.S. Androgen conjugates: Physiology and clinical significance. Endocr. Rev. 14: 121, 1993.
Narang R., Rao J., Savjani G., Petersen J. Radioimmunoassay kit for the quantitative measurement of serum androstanediol glucuronide in unextracted serum. Clin. Chem. 37: 1049A, 1991.
Andre M., Valsamis J. Reference values for androstanediol glucuronide. Clin. Chem. 40: 162, 1994.
Schnakenburg v K., Bidlingmaier F., Knorr D. 17OHprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia. Eur. J. Pediatr. 133: 259, 1980.
Pang S., MacGillivray M., Wang M., Jeffries S., Clark A., Rosenthal I. 3-androstandediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion. J. Clin. Endocrinol. Metab. 73: 166, 1991.
Hatun S., Yordum N., Calikoglu A.S. Serum 3-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia. Eur. J. Endocrinol. 131: 504, 1994.
Wudy S.A., Wächter U.A., Homoki J., Teller W.M. 5a-androstane-3, 17β-diol and 5α-androstane-3α, 17β-diol glucuronide in plasma of normal children, adults and patients with idiopathic hirsutism: a mass spectrometric study. Eur. J. Endocrinol. 134: 87, 1996.
Meikle A.W., Odell W.D.: Effect of short- and long-term dexamethasone on 3α-androstanediol glucuronide in hirsute women. Fertil Steril 46: 227, 1986.
Horton R., Hawks D., Lobe R. 3a, 17β-Androstanediol glucuronide in plasma: a marker of androgen action in idiopathic hirsutism. J. Clin. Invest. 69: 1203, 1982.
Paulson R.J., Serafini P.C., Catalino J.A., Lobo R.A. Measurements of 3α,17β-androstanediol glucuronide in serum and urine and correlation with skin 5α-re-ductase activity. Fertil. Steril. 46: 222, 1986.
Lobo R.A., Shoupe D., Serafini P., Brinton D., Horton H. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil. Steril. 43: 200, 1985.
Scanlon M.J., Whorwood C.B., Franks S., Reed M.J., James V.H.T. Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction. Clin. Endocrinol. (Oxf.) 29: 529, 1988.
Pang S., Wang G., Jeffries S., Riddick L., Clark A., Estrada E. Normal and elevated 3α-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels. J. Clin. Endocrinol. Metab. 75: 243, 1992.
Riddick L., Garibaldi L., Wang M., Senne A.R., Klimah P.E., Clark A.T. 3α-androstanediol glucuronide in premature and normal pubarche. J. Clin. Endocrinol. Metab. 72: 46, 1991.
Balducci R., Finocchi G., Mangiantini A., Bianchi P., Gugulielmi R., Toscane V. Plasma 3α-androstanediol glucuronide in precocious puberty. J. Endocrinol. Inves. 16: 117, 1993.
Reiner B.J., Donohoue P.A., Migeon C.J., Berkovitz G.D. Serum 3α-Androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy. J. Clin. Endocrinol. Metab. 69: 105, 1989.
Gilad S., Chayen R., Tordjman K., Kisch E., Stern N. Assessment of 5α-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion. Clin. Endocrinol. (Oxf.) 40: 459, 1994.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rittner, H.L., Lee, P.D.K., Blum, W.F. et al. Developmental patterns of serum 3α-androstanediol glucuronide. J Endocrinol Invest 20, 138–143 (1997). https://doi.org/10.1007/BF03346892
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346892